Crestline Management, LP, 10% Owner at Denali Therapeutics Inc. (DNLI), sold 2,886,494 shares at $31.65 ($91.4M) on 2020-08-12, disclosed to the SEC on 2020-08-14.
Open-market sale of $91.4M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.65 | 1,443,247 | $45.7M | 50.0% |
| 2 | $31.65 | 1,443,247 | $45.7M | 50.0% |
| Total | $31.65 avg | 2,886,494 | $91.4M | 100% |